Blueprint Medicines Corp (NAS:BPMC)
$ 96.53 -1.09 (-1.12%) Market Cap: 6.13 Bil Enterprise Value: 5.94 Bil PE Ratio: 0 PB Ratio: 19.54 GF Score: 81/100

Blueprint Medicines Corp Annual Shareholders Meeting Transcript

Jun 23, 2020 / 07:30PM GMT
Release Date Price: $78.94 (-0.42%)
Operator

Good afternoon, ladies and gentlemen, and welcome to the Blueprint Medicines Annual Shareholder Meeting. At this time, the meeting will begin. It is now my pleasure to turn the floor over to your host, Jeffrey Albers. Sir, the floor is yours.

Jeffrey W. Albers
Blueprint Medicines Corporation - CEO, President & Director

Thank you, and good morning, ladies and gentlemen. It's a pleasure to welcome you to our 2020 annual meeting of stockholders, which is being held virtually this year via the Internet. I'm Jeff Albers, President and Chief Executive Officer of Blueprint Medicines, and I'll serve as Chair of this meeting. Chris Frankenfield, our Vice President, Corporate Legal Affairs, will serve as Secretary Pro Tem and guide us through the proceedings today.

With that, I now call the meeting to order and will hand it over to Chris to conduct the formal business of the meeting.

Christopher Frankenfield
Blueprint Medicines Corporation - VP of Corporate Legal Affairs

Thanks, Jeff. The business before this

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot